Practical Biostatistics for Clinical Trials: How to Find and Use Your Biostat...NAMSA
Practical Biostatistics for Clinical Trials: How to Find and Use Your Biostatistician focusses on how to go about finding and using your biostatistician.
The Statisticians Role in Pharmaceutical DevelopmentAshwani Dhingra
Statistics plays an important role in drug development. Its use is necessary for planning and analysing trials and using statistics correctly is crucial for the success of drug development programs.
complete description of causality assessment with the definition of basic terminologies.& relation with an adverse event and adverse drug reaction, causality terms & assessment criteria.
Practical Biostatistics for Clinical Trials: How to Find and Use Your Biostat...NAMSA
Practical Biostatistics for Clinical Trials: How to Find and Use Your Biostatistician focusses on how to go about finding and using your biostatistician.
The Statisticians Role in Pharmaceutical DevelopmentAshwani Dhingra
Statistics plays an important role in drug development. Its use is necessary for planning and analysing trials and using statistics correctly is crucial for the success of drug development programs.
complete description of causality assessment with the definition of basic terminologies.& relation with an adverse event and adverse drug reaction, causality terms & assessment criteria.
This is an updated slide deck discussing what students should consider when starting a career in community pharmacy practice. There really are a lot of opportunities if pharmacists are willing to do what it takes to succeed.
Final Presentation for Block 6
Objectives:
Describe the mechanism of action, side-effects and counseling points for GLP-1 RA
Compare and contrast GLP-1 RA studies
Discuss the PIONEER-6 study and its implications to clinical practice
Bentracimab (also known as PB2452) is a neutralizing recombinant human immunoglobulin G1 monoclonal antibody antigen-binding fragment that binds ticagrelor and its major active circulating metabolite with high affinity and specificity
This is an updated slide deck discussing what students should consider when starting a career in community pharmacy practice. There really are a lot of opportunities if pharmacists are willing to do what it takes to succeed.
Final Presentation for Block 6
Objectives:
Describe the mechanism of action, side-effects and counseling points for GLP-1 RA
Compare and contrast GLP-1 RA studies
Discuss the PIONEER-6 study and its implications to clinical practice
Bentracimab (also known as PB2452) is a neutralizing recombinant human immunoglobulin G1 monoclonal antibody antigen-binding fragment that binds ticagrelor and its major active circulating metabolite with high affinity and specificity
Presentation working on clinical trialsSarah Henter
Working on Clinical Trials – Getting started
Very few clinical trials are conducted only in one country; many are available in a variety of different sites in different places, so the translation and linguistic adaptation for different target cultures and languages becomes more important – but it’s not easy to find professionals who specialize in this specific field. With my presentation I hope to provide an overview of what makes the linguistic work on clinical trials so special, what kind of texts and target audiences there are and what knowledge linguists need to acquire in order to efficiently work in this area. This is especially interesting for translators who already specialize in the medical field, but also for linguists interested in legal, business, marketing and related field who would like to add an interesting niche with high demand to their specialization.
The presentation aims to be an introduction to the characteristics and requirements of the linguistic work on texts related to clinical trials. It not only wants to give a brief overview of how clinical trials work and who the stakeholders are, but also underline the skills and knowledge set linguists who would like to further specialize in this field should acquire. It also provides them with the necessary resources to get them started. The main topics are as follows:
• Introduction to clinical trials (what are they; how do they work; who is implied)
• Types of documents used in clinical trials (medical [specialist facing/ patient facing]; legal; marketing, etc.)
• Types of audiences (doctors/investigators/healthcare providers; patients/ other laymen such as healthy subjects/ partners/ legal representatives/ parents, etc.; ECs; CROs…)
• What skills do linguists need to work in this field?
• How to acquire that knowledge?
- Where to find glossaries/ templates/ further information
- MOOCs to take to get you started
- Books you should have read
- Other handy resources
Lagunas en la formación universitaria de los traductores europeosSarah Henter
¿Los traductores están contentos con su formación universitaria? Presentado en CILLEC IV en UCAM Murcia
https://sites.google.com/a/ucam.edu/cillec-iv/home
Business English, English for Marketing and Sales, Expresiones, Expressions, frases hechas, Inglés para Marketing y Ventas, Inglés para Negocios, vocabulario
Business English, English for Marketing and Sales, Expresiones, Expressions, frases hechas, Inglés para Marketing y Ventas, Inglés para Negocios, vocabulario
1. NIDA Clinical Trials Network
Certificate of Completion
is hereby granted to
Sarah Henter
to certify your completion of the six-hour required course on:
GOOD CLINICAL PRACTICES
MODULE: STATUS:
Introduction N/A
Institutional Review Boards Passed
Informed Consent Passed
Confidentiality & Privacy Passed
Participant Safety & Adverse Events Passed
Quality Assurance Passed
The Research Protocol Passed
Documentation & Record-Keeping Passed
Research Misconduct Passed
Roles & Responsibilities Passed
Recruitment & Retention Passed
Investigational New Drugs Passed
Course Completion Date: 14 June 2016
CTN Expiration Date: 14 June 2019
Tracee Williams, Training Coordinator
NIDA Clinical Coordinating Center
This training has been funded in whole or in part with Federal funds from the National Institute on Drug Abuse, National
Institutes of Health, Department of Health and Human Services, under Contract No. HHSN27201201000024C.
